PeptideAtlas

PEPTIDEATLAS / LIBRARY

How to read clinical trial results

Six checks behind a headline: participants, comparator, duration, outcomes, safety and source.

PeptideAtlas ·

1. Who does the result describe?

Check the participant count and eligibility criteria. Findings describe the studied population; do not assume they apply equally to everyone. Note the duration too: a change after a few weeks and a change after a year answer different questions.

2. What was the comparator?

Look for a control group, placebo or active comparator. Randomization means assignment by chance. Two percentages from separate trials do not rank molecules on their own: populations and study designs may differ.

3. What was actually measured?

Find the prespecified primary and secondary outcomes in the registry and match them to the reported results. A laboratory measurement and a clinical event are different outcomes. Do not replace the main research question with the most striking number.

4. What do we know about safety?

Read adverse events and participant flow, including discontinuations. Benefits and safety belong together. If a short announcement omits information, record it as missing.

5. What kind of source is this?

A company announcement, a registry record and a research paper are different documents. Find the trial identifier and update date. Registry information is submitted by the sponsor or investigator; registration itself is not an independent recommendation.

6. What does the phase mean?

Early phases explore safety and initial signals of effect; later phases assess effectiveness and adverse effects in larger groups. Phase 3 does not automatically mean an authorised medicine. A clinical result does not certify an online catalogue product.

A useful note beside a headline

Write down: trial → participants → comparator → duration → primary result → adverse events → source. Leave a question mark where information is missing. This is an editorial reading checklist, not a tool for selecting treatment.

Primary sources

Continue reading

All guides · Retatrutide · Survodutide · Cagrilintide · CagriSema · Zenagamtide (amycretin) · MariTide (maridebart cafraglutide) · Active catalogue